4//SEC Filing
ISIS PHARMACEUTICALS INC 4
Accession 0000874015-05-000014
$IONSCIK 0000874015operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 7:39 PM ET
Size
6.0 KB
Accession
0000874015-05-000014
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Award
Common Stock
2005-05-25+10,000→ 10,000 totalExercise: $3.94From: 2009-05-25Exp: 2012-05-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Grant of 5-25-05 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 5-25-06. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 2,500 shares per year. The option is exercisable as to 0 shares on 5-25-05.
Documents
Issuer
ISIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000874015
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 7:39 PM ET
- Size
- 6.0 KB